Status: current, Defined. Date: 30-Jun 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4404141000168117 | calcium carbonate 187.5 mg + sodium alginate 250 mg + sodium bicarbonate 106.5 mg chewable tablet, 62 tablets (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4404151000168115 | sodium alginate 250 mg + sodium bicarbonate 106.5 mg + calcium carbonate 187.5 mg chewable tablet, 62 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| sodium alginate 250 mg + sodium bicarbonate 106.5 mg + calcium carbonate 187.5 mg chewable tablet, 62 | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| sodium alginate 250 mg + sodium bicarbonate 106.5 mg + calcium carbonate 187.5 mg chewable tablet, 62 | has MPUU | sodium alginate 250 mg + sodium bicarbonate 106.5 mg + calcium carbonate 187.5 mg chewable tablet | true | Inferred relationship | Some | 1749239616 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Gaviscon Dual Action Peppermint chewable tablet, 62 | Is a | True | sodium alginate 250 mg + sodium bicarbonate 106.5 mg + calcium carbonate 187.5 mg chewable tablet, 62 | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR